Tucson, AZNCT07547215Now EnrollingIRB Ready

Sacroiliac Joint Dysfunction Clinical Trial in Tucson, AZ

Access cutting-edge sacroiliac joint dysfunction treatment through this clinical trial at a research site in Tucson. Study-provided care at no cost to qualified participants.

Sponsored by PainTEQ, LLC

Quick Self-Assessment

See if you qualify for this Tucson location

Preparing your pre-screening questions…

Expert Care in Tucson

Access sacroiliac joint dysfunction specialists at no cost

IRB Approved

This study follows strict safety protocols and ethical guidelines

No-Cost Care

All study-related sacroiliac joint dysfunction treatment provided free

Apply for This Tucson Location

Check if you qualify for this sacroiliac joint dysfunction clinical trial in Tucson, AZ

Secure & Confidential

Your information is protected and will only be shared with the research team.

Why Participate?

  • No-Cost Study Care

  • Local to Tucson

    Convenient for AZ residents

  • Cutting-Edge Treatment

    Access to innovative therapies

  • Expert Medical Care

    Close monitoring by specialists

  • Possible Compensation*

    For time and travel

*Compensation varies by study. Confirm details with coordinator.

Simple Process

  1. 1Submit this form
  2. 2Phone screening
  3. 3Visit Tucson site if eligible
  4. 4Begin participation

About This Sacroiliac Joint Dysfunction Study in Tucson

The purpose of this study is to evaluate the real-world performance, safety and efficacy of the TRAQ System.

Sponsor: PainTEQ, LLC

Who Can Participate

Inclusion Criteria

To be eligible to participate in this study, a subject must meet all the following criteria, as determined by the Investigator:
Age and Body Mass Index (BMI)
Adult patients aged ≥ 21 years at screening.
Chronic SIJ Related Pain
Has experienced low back and/or buttock pain for at least 6 months that has been inadequately responsive to non surgical management.
Has experienced nonradicular pain that is maximal below the L5 vertebrae, localized over the posterior SIJ, and consistent with SIJ pain.
Diagnosis of SIJ Dysfunction a. Has a diagnosis of SIJ dysfunction (degenerative sacroiliitis or SIJ disruption) based on ALL of the following: i. A positive Fortin's finger test; and ii. Pain elicited on at least three (3) of five (5) SIJ specific physical examination maneuvers (FABER test, Gaenslen's test, Distraction, Thigh Thrust, Compression); and iii. At least 75% reduction in pain, with associated improvement in previously painful maneuvers, for the expected duration of action following two (2) image guided, contrast enhanced intra articular diagnostic SIJ injections, performed on separate visits using anesthetics with different durations of action; and iv. Completion of at least one (1) therapeutic intra articular SIJ injection (e.g., corticosteroid injection) within the past 12 months.
Baseline Disability and Pain Severity a. Baseline Oswestry Disability Index (ODI) score ≥30%; and b. Baseline SI joint pain score of ≥60 mm on a 100 mm Visual Analog Scale (VAS).
Treatment Decision a. The treating physician has independently determined that the TRAQ procedure is an appropriate treatment option for the subject's SIJ dysfunction in the course of routine clinical care, and the subject has agreed to undergo this treatment.
Informed Consent and Compliance
Is willing and capable of providing written informed consent; and
Is willing and able to comply with all study related requirements, procedures, and follow up visits.

Exclusion Criteria

Subjects must meet none of the following criteria to be eligible for participation in this study, as determined by the Investigator:
Pain Source Uncertainty a. Inability to confirm, in the Investigator's clinical judgment, that the subject's primary pain generator is the sacroiliac joint.
Alternative Primary Spine Pathology a. Presence of severe low back pain attributable to other spinal pathology, including but not limited to lumbar disc degeneration, lumbar disc herniation, lumbar spondylolisthesis, lumbar spinal stenosis, lumbar facet degeneration, or lumbar vertebral body fracture.
Other Sacroiliac Pathology a. Presence of known sacroiliac joint pathology other than degenerative SIJ dysfunction, including inflammatory sacroiliitis (e.g., ankylosing spondylitis or other HLA associated spondyloarthropathies), tumor, infection, acute fracture, or crystal arthropathy.
Non SIJ Pain Syndromes a. History of coccydynia or prior coccygectomy, endometriosis, cluneal neuralgia, or pudendal neuralgia.
Recent Sacral Interventions a. Prior sacral radiofrequency ablation performed within 6 months prior to enrollment.
Recent Pelvic Trauma a. History of major pelvic trauma within 12 months prior to enrollment.
Severe Osteoporosis a. Prior diagnosis or suspicion of severe osteoporosis, defined as a prior bone mineral density T score of \< -2.5 or a history of osteoporotic fracture.
Medications Affecting Bone or Soft Tissue Healing a. Current use of medications known to adversely affect bone quality or soft tissue healing, as determined by the Investigator.
Anatomic Constraints a. Anatomic anomalies or defects that, in the Investigator's opinion, would preclude safe or biomechanically appropriate device placement.
Systemic Inflammatory or Rheumatologic Disease a. Presence of a chronic inflammatory rheumatologic condition, such as rheumatoid arthritis.
Centralized Pain Syndromes a. Current diagnosis of fibromyalgia.
Infection Risk a. Evidence of current local or systemic infection that would increase surgical risk.
High-Dose Opioid Therapy (≥90 MME/day) a. Current use of systemic opioid analgesics at Screening/Baseline with an average daily dose ≥90 morphine milligram equivalents (MME/day), based on medication reconciliation (prescription records and subject report) and standard MME conversion factors.
Current Nicotine Use (Self-Reported) a. Self-reported use of any nicotine-containing products (including smoking, vaping/e-cigarettes, cigars, pipes, smokeless tobacco, nicotine pouches, and nicotine replacement products) within 6 weeks prior to Screening/Baseline.
Secondary Gain or Litigation a. Currently receiving or actively seeking workers' compensation or disability benefits or involved in injury related litigation.
Pregnancy a. Currently pregnant or planning to become pregnant within two (2) years following enrollment, as self reported.
Vulnerable Populations a. Individuals who are prisoners or wards of the state.
Substance Abuse a. Known or suspected active drug or alcohol abuse, including opioid misuse.
Psychiatric Conditions a. Diagnosed psychiatric disorder (e.g., schizophrenia, major depressive disorder, personality disorder) that, in the Investigator's judgment, could interfere with study participation.
Concurrent Interventional Research a. Current participation in another clinical trial.
Neurologic Conditions Affecting Rehabilitation a. Presence of a significant neurologic disorder that would interfere with participation in physical therapy or post procedural rehabilitation.
Other Confounding Medical Conditions a. Any other medical condition or pain condition not intended to be treated in this study that, in the Investigator's judgment, could interfere with study procedures, accurate pain reporting, or interpretation of study endpoints.

Not sure if you qualify? Submit your interest and a study coordinator will help determine your eligibility.

Frequently Asked Questions

Q:Is this study available in Tucson?

Yes, this clinical trial (NCT07547215) has an active research site in Tucson, AZ that is currently enrolling participants.

Q:Is it safe to participate?

Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.

Q:Will I be compensated?

Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.

Q:Can I leave the trial if I change my mind?

Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.

Still have questions? Our study coordinators are here to help.

Sacroiliac Joint Dysfunction Treatment Options in Tucson, AZ

If you're searching for sacroiliac joint dysfunction treatment options in Tucson, AZ, this clinical trial (NCT07547215) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.

Our Tucson research site is actively enrolling participants for this clinical trial. You'll receive care from experienced sacroiliac joint dysfunction specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.

Looking for more options? Browse all sacroiliac joint dysfunction clinical trials near you to find additional studies recruiting in your area.

More Osteogenesis Imperfecta Trials in Tucson, AZ

See all osteogenesis imperfecta clinical trials recruiting in Tucson — not just this study.

Browse Osteogenesis Imperfecta Trials in Tucson →

Browse More Trials by Condition

Osteogenesis Imperfecta TrialsAll Conditions →

Ready to Join in Tucson?

Take the first step toward participating in this groundbreaking clinical trial

Secure · Expert Care · Tucson, AZ